DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Operating cash flow
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.0MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMIIR financial trends
DMIIR RevenueDMIIR Net incomeDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating incomeDMIIR Operating marginDMIIR Free cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR Shareholders’ equityDMIIR overview →